Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124776085 | 12477608 | 5 | F | 20160609 | 20160803 | 20160617 | 20160809 | EXP | MX-BAYER-2016-115983 | BAYER | 62.00 | YR | A | F | Y | 48.00000 | KG | 20160809 | CN | MX | MX |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124776085 | 12477608 | 1 | PS | NEXAVAR | SORAFENIB | 1 | 400 MG, BID | 21923 | 400 | MG | FILM-COATED TABLET | BID | |||||||
124776085 | 12477608 | 2 | C | LOSARTAN. | LOSARTAN | 1 | 2 DF, QD | 0 | 2 | DF | QD | ||||||||
124776085 | 12477608 | 3 | C | METOPROLOL. | METOPROLOL | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
124776085 | 12477608 | 4 | C | INSULIN | INSULIN NOS | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124776085 | 12477608 | 1 | Hepatocellular carcinoma |
124776085 | 12477608 | 2 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124776085 | 12477608 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124776085 | 12477608 | Alopecia | |
124776085 | 12477608 | Asthenia | |
124776085 | 12477608 | Diarrhoea | |
124776085 | 12477608 | Discomfort | |
124776085 | 12477608 | Fatigue | |
124776085 | 12477608 | Hepatic pain | |
124776085 | 12477608 | Hyperglycaemia | |
124776085 | 12477608 | Hypertension | |
124776085 | 12477608 | Hypoaesthesia | |
124776085 | 12477608 | Hypoglycaemia | |
124776085 | 12477608 | Injection site haemorrhage | |
124776085 | 12477608 | Muscular weakness | |
124776085 | 12477608 | Myalgia | |
124776085 | 12477608 | Oedema peripheral | |
124776085 | 12477608 | Skin induration | |
124776085 | 12477608 | Somnolence | |
124776085 | 12477608 | Systemic lupus erythematosus | |
124776085 | 12477608 | Thirst | |
124776085 | 12477608 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124776085 | 12477608 | 1 | 20160328 | 0 |